Lifeworks Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$862K Buy
9,399
+2,128
+29% +$186K 0.09% 148
2026
Q1
$620K Sell
7,271
-1,484
-17% -$132K 0.08% 167
2025
Q4
$692K Buy
8,755
+1,322
+18% +$104K 0.09% 175
2025
Q3
$594K Sell
7,433
-26
-0.3% -$2.22K 0.08% 188
2025
Q2
$678K Sell
7,459
-891
-11% -$81.3K 0.1% 162
2025
Q1
$782K Buy
8,350
+784
+10% +$70.2K 0.13% 142
2024
Q4
$688K Sell
7,566
-817
-10% -$78K 0.12% 142
2024
Q3
$870K Sell
8,383
-624
-7% -$63.6K 0.17% 125
2024
Q2
$874K Sell
9,007
-657
-7% -$60.6K 0.24% 91
2024
Q1
$870K Sell
9,664
-1,475
-13% -$125K 0.24% 96
2023
Q4
$888K Sell
11,139
-1,104
-9% -$83K 0.31% 85
2023
Q3
$871K Buy
12,243
+3,703
+43% +$277K 0.34% 84
2023
Q2
$658K Buy
8,540
+3,476
+69% +$269K 0.28% 90
2023
Q1
$381K Buy
+5,064
New +$377K 0.18% 116
2022
Q4
Sell
-3,371
Closed -$249K 116
2022
Q3
$249K Buy
3,371
+395
+13% +$31K 0.14% 113
2022
Q2
$238K Buy
+2,976
New +$233K 0.15% 117

Other funds holding CL

Lifeworks Advisors's CL Position: Q2 2026 in Review

Lifeworks Advisors increased its Colgate-Palmolive (CL) stake by 29% in Q2 2026, buying an estimated $186K and bringing the position to 9,399 shares worth $862K. The position accounts for 0.09% of the portfolio, ranked #148.

Lifeworks Advisors first reported a position in CL in Q2 2022 and has held it in 16 quarters since. The position peaked at $888K in Q4 2023. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Lifeworks Advisors held 9,399 shares of Colgate-Palmolive worth $862K as of Q2 2026.
  • Lifeworks Advisors bought 2,128 Colgate-Palmolive shares in Q2 2026, an estimated $186K.
  • Colgate-Palmolive made up 0.09% of Lifeworks Advisors's portfolio in Q2 2026, its #148 holding.
  • Lifeworks Advisors first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 16 quarters since.
  • Lifeworks Advisors's Colgate-Palmolive position peaked at $888K in Q4 2023.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Lifeworks Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.